Treatment
Ampicillin clinical trials
We’re tracking 11 recruiting studies that include Ampicillin, each written for real people, not researchers, below.
Recruiting studies
- NCT07610486RecruitingPhase 1/Phase 2
Optimizing Ampicillin Dosing for Preterm Infants
This study aims to find the best dose of ampicillin for premature babies in the NICU who are being treated for possible early infection. The goal is to improve treatment and reduce side effects.
Durham, North CarolinaAges birth–1 week - NCT06423898RecruitingPhase 4
Study on ampicillin and ceftriaxone for heart valve infection
This trial tests a combination of two antibiotics (ampicillin and ceftriaxone) to treat a heart valve infection caused by Enterococcus faecalis bacteria. It aims to see how well the medicine works and if it's safe.
AlavaAges 18 years+ - NCT05469984Recruiting
Two antibiotic plans for water breaking before labor
This trial compares two different “preventive” antibiotic schedules for pregnant people whose water breaks more than 18 hours before labor, or who go into preterm labor. The goal is to see which plan better helps mother and baby by reducing infection-related complications.
NahariyaAges 18–48 - NCT05922124RecruitingPhase 4
Testing two antibiotics against resistant lung and bloodstream infections
This trial studies whether cefiderocol plus ampicillin-sulbactam works better than colistin (sometimes with meropenem) for serious infections caused by carbapenem-resistant Acinetobacter baumannii (a hard-to-treat germ). It may help by finding a more effective antibiotic plan for people with these severe hospital-acquired infections.
HaifaAges 16 years+ - NCT06494072RecruitingPhase 4
Short vs standard antibiotics for kids hospitalized with pneumonia
This trial compares a shorter course of antibiotics to the usual longer course for children hospitalized with uncomplicated bacterial pneumonia. The goal is to see if fewer days of antibiotics work just as well, which could reduce side effects and make treatment easier.
Milwaukee, WisconsinAges 3 months–18 years - NCT07183462RecruitingPhase 4
Antibiotic treatment for late preterm water breaking
This trial tests whether a combination of two antibiotics (azithromycin and ampicillin) can help pregnant people whose water has broken between 34 and 36 weeks of pregnancy. The goal is to see if this treatment improves outcomes for both the parent and baby without causing early labor or infection.
Ramat Gan, IsraelAges 18–50 - NCT07118384Recruiting
Comparing two antibiotics for drug-resistant infections
This trial tests two different antibiotic combinations (ampicillin/sulbactam and cefoperazone/sulbactam) to see which works better against a type of bacteria (Acinetobacter baumannii) that is resistant to many other drugs. It is for critically ill patients with signs of sepsis.
CairoAges 21 years+ - NCT07326540RecruitingPhase 3
Testing a new antibiotic for drug-resistant pneumonia in the hospital
This trial compares a new antibiotic (BV100 plus low-dose polymyxin B) against a standard treatment for pneumonia caused by a hard-to-treat bacteria (Acinetobacter baumannii). If you have hospital-acquired or ventilator-associated pneumonia and standard antibiotics aren't working, this study may offer a new option.
TbilisiAges 18–82 - NCT06336213Recruiting
Using a blood test to guide antibiotics in aorta surgery
This trial checks if a blood test called presepsin can help doctors decide when to use antibiotics in patients having surgery on the chest's main artery (the thoracic aorta). It is for people with an aneurysm or tear in that artery.
Moscow, MoscowAges 18–75 - NCT06396078RecruitingPhase 4
Antibiotics for Early Water Breaking Before Delivery
This study tests whether giving antibiotics to pregnant people with early water breaking (PPROM) before delivery improves outcomes. It aims to prevent infections and protect both parent and baby while waiting for delivery.
Columbus, OhioAges 18 years+ - NCT06406114RecruitingPhase 2
Better Allergy Testing for Cephalosporin Antibiotics
This study tests better ways to diagnose allergies to common cephalosporin antibiotics, like Keflex and Rocephin. By participating, you may learn if you are truly allergic to these medicines and if they are safe for you to take in the future.
Scottsdale, ArizonaAges 18–70
What Ampicillin is being studied for
Conditions with recruiting Ampicillin studies.
Common questions
- Are there clinical trials studying Ampicillin?
- Yes. Clin2 currently lists 11 recruiting studies that include Ampicillin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Ampicillin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Ampicillin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Ampicillin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.